Cyclical changes in susceptibility of a myeloma tumor (LPC-1) to immune destruction. III. Periodic production of a cell surface glycoprotein and changes in reactivity with cytotoxic T cells and anti-H-2d sera.
D000818:Animals; D002918:Chymotrypsin / Q000494:pharmacology; D003602:Cytotoxicity, Immunologic; D004591:Electrophoresis, Polyacrylamide Gel; D006023:Glycoproteins / Q000096:biosynthesis*; D006183:H-2 Antigens / Q000276:immunology; D007106:Immune Sera / Q000494:pharmacology*; D008297:Male; D008565:Membrane Proteins / Q000096:biosynthesis*; D051379:Mice; D008807:Mice, Inbred BALB C; D010954:Plasmacytoma / Q000276:immunology*; D013381:Subtilisins / Q000494:pharmacology; D013601:T-Lymphocytes / Q000276:immunology*; D013997:Time Factors; D014357:Trypsin / Q000494:pharmacology
D006023:Glycoproteins; D006183:H-2 Antigens; D007106:Immune Sera; D008565:Membrane Proteins; D013381:Subtilisins; D002918:Chymotrypsin; D014357:Trypsin